| Early Translational III | University of California, San Diego | Human ES cell based therapy of heart failure without allogenic immune rejection |
$1,857,600 |
| Early Translational I | University of California, San Diego | Developing induced pluripotent stem cells into human therapeutics and disease models |
$5,165,028 |
| Transplantation Immunology | University of California, San Diego | Induction of immune tolerance to human embryonic stem cell-derived allografts |
$1,192,680 |
| Comprehensive Grant | University of California, San Diego | Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells |
$2,467,200 |
